Literature DB >> 14652169

Transplantation treatment of spinal cord injury patients.

Samuil S Rabinovich1, Victor I Seledtsov, Olga V Poveschenko, Vladimir V Senuykov, Vadim Y Taraban, Vladimir I Yarochno, Nicolay G Kolosov, Sergey A Savchenko, Vladimir A Kozlov.   

Abstract

The minimally manipulated cells from fetal nervous and hemopoietic tissues (gestational age 16-22 weeks) were subarachnoidally implanted into 15 patients (18-52 years old) with severe consequences of traumatic spinal cord injury (SCI) at cervical or thoracic spine level. The times after SCI were from 1 month to 6 years. Each patient underwent from one to four cell transplantations (CT) with various time intervals. In 11 of 15 cases, CT was combined with an operative partial disruption of a connective tissue cyst and with implantation into a spinal cord lesion of a spinal cord fragment together with olfactory ensheathing cells. Before CT the patients showed complete motor and sensory function disorder consistent with a grade A of SCI according to Frankel classification. With CT treatment, six patients improved their neurological status from A to C grade of SCI, exhibiting incomplete restoration of both motor and sensory function. The status of other five CT-treated patients became consistent with SCI grade B and was characterized by appearance of contracting activity in some muscles and incomplete restoration of sensitivity. The remaining four patients did not exhibit any clinical improvements. No serious complications of CT were noted. The results suggest a clinical relevance of the CT-based approach to treating severe consequences of SCI.

Entities:  

Mesh:

Year:  2003        PMID: 14652169     DOI: 10.1016/j.biopha.2003.05.001

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

2.  Safety profile, feasibility and early clinical outcome of cotransplantation of olfactory mucosa and bone marrow stem cells in chronic spinal cord injury patients.

Authors:  Vijay G Goni; Rajesh Chhabra; Ashok Gupta; Neelam Marwaha; Mandeep S Dhillon; Sudesh Pebam; Nirmal Raj Gopinathan; Shashidhar Bangalore Kantharajanna
Journal:  Asian Spine J       Date:  2014-08-19

Review 3.  Progress and prospects in neurorehabilitation: clinical applications of stem cells and brain-computer interface for spinal cord lesions.

Authors:  Mariana Gongora; Caroline Peressutti; Sergio Machado; Silmar Teixeira; Bruna Velasques; Pedro Ribeiro
Journal:  Neurol Sci       Date:  2012-11-17       Impact factor: 3.307

4.  Directing dopaminergic fiber growth along a preformed molecular pathway from embryonic ventral mesencephalon transplants in the rat brain.

Authors:  Y Jin; C Zhang; K S Ziemba; G A Goldstein; P G Sullivan; G M Smith
Journal:  J Neurosci Res       Date:  2011-02-17       Impact factor: 4.164

5.  Recovering Voiding and Sex Function in a Patient with Chronic Complete Spinal Cord Injury by Olfactory Ensheathing Cell Transplantation.

Authors:  Di Chen; Haitao Xi; Ke Tan; Hongyun Huang
Journal:  Case Rep Neurol Med       Date:  2022-07-06

6.  Olfactory nerve recovery following mild and severe injury and the efficacy of dexamethasone treatment.

Authors:  Masayoshi Kobayashi; Richard M Costanzo
Journal:  Chem Senses       Date:  2009-07-03       Impact factor: 3.160

Review 7.  Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis.

Authors:  Lei Li; Hafeez Adnan; Benchen Xu; Jianmin Wang; Chengke Wang; Fang Li; Kai Tang
Journal:  Eur Spine J       Date:  2014-07-08       Impact factor: 3.134

Review 8.  Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).

Authors:  Hongyun Huang; Wise Young; Stephen Skaper; Lin Chen; Gustavo Moviglia; Hooshang Saberi; Ziad Al-Zoubi; Hari Shanker Sharma; Dafin Muresanu; Alok Sharma; Wagih El Masry; Shiqing Feng
Journal:  J Orthop Translat       Date:  2019-11-11       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.